Developer docs
API playgroundTry for free, no card

Search company profiles

Biodue

Full company profile

uuid0037gs3

Namestring
Biodue
Legal namestring
BioDue S.p.A.
Websiteurl
biodue.com
Company typeenum
Private
Founded yearint
1986
Short descriptiontext

Biodue S.p.A. is an Italian CDMO founded in 1986 that develops, manufactures, and packages food supplements, medical devices, and cosmetics for European pharmaceutical, nutraceutical, and consumer healthcare clients under long-term manufacturing agreements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSambuca, Italy
HQ citystring
Sambuca
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract manufacturing services, food supplement manufacturing, medical device production, cosmetic contract manufacturing, nutraceutical CDMO
Industry2 codes
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Contract Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1CDMO Manufacturing Services
TypeManaged Services
Description

Contract development and manufacturing organization providing full-service B2B offerings including raw material sourcing, development and formulation, production, packaging, regulatory affairs, and commercialization of food supplements, medical devices, and cosmetics. Revenue generated through long-term manufacturing agreements and exclusive production contracts with clients.

biodue.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Farcoderma
Description

Part of Healthea Group portfolio of companies, focused on health care products manufacturing.

biodue.com
+2 more records
Core offering1 text field

Biodue is an Italian Contract Development and Manufacturing Organization (CDMO) that produces food supplements, medical devices, and cosmetics for third-party brands. The company operates seven manufacturing plants with more than 100 production lines and serves clients across 30 countries. Its offering combines R&D, formulation development, manufacturing, packaging, and regulatory support under proprietary platforms such as Caps in Caps technology.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biodue is an Italian CDMO (Contract Development and Manufacturing Organization) founded in 1986 that provides integrated manufacturing services for the health care sector. The company operates through three core product categories—Food Supplements, Medical Devices, and Cosmetics—supported by its proprietary Caps in Caps technology for advanced oral dosage delivery. Its offering spans the entire product lifecycle from R&D and formulation development through production and packaging to regulatory affairs and commercialization. Biodue is part of the Healthea Group and serves both large pharma and nutraceutical companies as well as niche operators across Europe.

Product and service1 record
1Food Supplement Manufacturing
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-11
Description

UK-quoted consumer healthcare group from which BioDue acquired CDMO business unit including Biokosmes and Rolf Kullgren brands. At closing, VLG enters into a long-term manufacturing agreement with BioDue for exclusive production of its products. Approximately 70% of the acquired business unit's sales come from medical devices, complementing BioDue's traditional focus on food supplements.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Italian B2B company carved out from BioDue under Riverside ownership, focused on development and out-licensing of innovative patented products for oral health, dermatology, and broader nutraceutical industry.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Group of companies founded in 2025 with the aim of bringing together the best CDMOs in Europe under a single brand. BioDue is a founding member, along with FARCOS and other entities. The group provides one of the widest commercial offers in the healthcare sector on the European market.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

French-headquartered European CDMO providing contract development and manufacturing for pharma and consumer health. Comparable as a multi-site European CDMO serving brand-owner clients, with similar B2B service orientation.

2Fareva
TypeDirect peer
Description

European CDMO offering contract manufacturing for pharmaceuticals, cosmetics, and FMCG. Highly comparable to Biodue in product category breadth (pharma, cosmetics, consumer health), B2B service model, and mid-market European positioning.

3Recipharm
TypeDirect peer
Description

Swedish-headquartered CDMO with multiple European manufacturing sites serving pharma and consumer health clients. Comparable as a multi-site European contract manufacturer, though with a stronger prescription-pharma tilt than Biodue's nutraceutical-heavy mix.

TypeBroad incumbent
Description

Global CDMO leader in API, biologics, and cell & gene therapy manufacturing. Comparable as a CDMO, but with a far larger and more biotech-oriented portfolio than Biodue's nutraceutical, medical-device, and cosmetics mix.

TypeDirect peer
Description

CDMO specializing in nutraceuticals and consumer health products, including gummies, softgels, and capsules. Comparable as a dedicated nutraceutical CDMO with proprietary delivery formats, directly overlapping with Biodue's food supplement focus and Caps in Caps positioning.

TypeBroad incumbent
Description

Global large-cap CDMO with extensive softgel, oral, sterile, and biologics capabilities. Comparable in CDMO service model and dosage-form breadth, but operates at a much larger scale and across broader therapeutic and biologics categories than Biodue.

TypeBroad incumbent
Description

International CDMO providing API, drug product, and packaging services across multiple dosage forms. Comparable in integrated CDMO model and European roots, though focused more on prescription pharma than consumer health.

TypeDirect peer
Description

European CDMO focused on solid oral dosage forms, semi-solids, and sterile fill-finish for pharma and consumer health. Comparable in CDMO service model, European footprint, and diversified dosage-form capabilities similar to Biodue's broad pharmaceutical-form portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biodue

Contract Pharmaceutical Manufacturingbiodue.com

Biodue S.p.A. is an Italian CDMO founded in 1986 that develops, manufactures, and packages food supplements, medical devices, and cosmetics for European pharmaceutical, nutraceutical, and consumer healthcare clients under long-term manufacturing agreements.

Biodue firmographics

Firmographics
Name
Biodue
Legal name
BioDue S.p.A.
Website
https://biodue.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
101–250 employees
Short description
Biodue S.p.A. is an Italian CDMO founded in 1986 that develops, manufactures, and packages food supplements, medical devices, and cosmetics for European pharmaceutical, nutraceutical, and consumer healthcare clients under long-term manufacturing agreements.
Ownership category
akta.pro rank

Biodue industry classification

Industry
Product category
Contract Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGABAG
Drug Substance–Drug Product Integrated CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Contract manufacturing services
  • Food supplement manufacturing
  • Medical device production
  • Cosmetic contract manufacturing
  • Nutraceutical CDMO

Where Biodue is headquartered

Location

Headquarters

HQ city
Sambuca
HQ country
Italy
HQ region
Europe

Offices6 records

Markets served

Biodue business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. CDMO Manufacturing Services: Contract development and manufacturing organization providing full-service B2B offerings including raw material sourcing, development and formulation, production, packaging, regulatory affairs, and commercialization of food supplements, medical devices, and cosmetics. Revenue generated through long-term manufacturing agreements and exclusive production contracts with clients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Biodue product offering

Product offering

Core offering

Biodue is an Italian Contract Development and Manufacturing Organization (CDMO) that produces food supplements, medical devices, and cosmetics for third-party brands. The company operates seven manufacturing plants with more than 100 production lines and serves clients across 30 countries. Its offering combines R&D, formulation development, manufacturing, packaging, and regulatory support under proprietary platforms such as Caps in Caps technology.

Product overview

Biodue is an Italian CDMO (Contract Development and Manufacturing Organization) founded in 1986 that provides integrated manufacturing services for the health care sector. The company operates through three core product categories—Food Supplements, Medical Devices, and Cosmetics—supported by its proprietary Caps in Caps technology for advanced oral dosage delivery. Its offering spans the entire product lifecycle from R&D and formulation development through production and packaging to regulatory affairs and commercialization. Biodue is part of the Healthea Group and serves both large pharma and nutraceutical companies as well as niche operators across Europe.

Differentiator

Problem solved

Functional benefit

Brands

  • Farcoderma: Part of Healthea Group portfolio of companies, focused on health care products manufacturing.
  • Healthea Group
  • Caps in Caps

Products and services

  • Food Supplement Manufacturing

Companies that use Biodue

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Biodue technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Biodue partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Venture Life Group plc (VLG)coreStrategic or Co-development Partner · 11 May 2025UK-quoted consumer healthcare group from which BioDue acquired CDMO business unit including Biokosmes and Rolf Kullgren brands. At closing, VLG enters into a long-term manufacturing agreement with BioDue for exclusive production of its products. Approximately 70% of the acquired business unit's sales come from medical devices, complementing BioDue's traditional focus on food supplements.
  • BMG PharmaminorStrategic or Co-development Partner · 1 January 2025Italian B2B company carved out from BioDue under Riverside ownership, focused on development and out-licensing of innovative patented products for oral health, dermatology, and broader nutraceutical industry.
  • Healthea GroupcoreStrategic or Co-development Partner · 1 January 2025Group of companies founded in 2025 with the aim of bringing together the best CDMOs in Europe under a single brand. BioDue is a founding member, along with FARCOS and other entities. The group provides one of the widest commercial offers in the healthcare sector on the European market.

Scale indicators8 records

Recent moves3 records

Expansion highlights6 records

Biodue competitors and assessment

Company assessment

Direct peers

  • Delpharm: French-headquartered European CDMO providing contract development and manufacturing for pharma and consumer health. Comparable as a multi-site European CDMO serving brand-owner clients, with similar B2B service orientation.
  • Fareva: European CDMO offering contract manufacturing for pharmaceuticals, cosmetics, and FMCG. Highly comparable to Biodue in product category breadth (pharma, cosmetics, consumer health), B2B service model, and mid-market European positioning.
  • Recipharm: Swedish-headquartered CDMO with multiple European manufacturing sites serving pharma and consumer health clients. Comparable as a multi-site European contract manufacturer, though with a stronger prescription-pharma tilt than Biodue's nutraceutical-heavy mix.
  • Sirio Pharma: CDMO specializing in nutraceuticals and consumer health products, including gummies, softgels, and capsules. Comparable as a dedicated nutraceutical CDMO with proprietary delivery formats, directly overlapping with Biodue's food supplement focus and Caps in Caps positioning.
  • Aenova Group: European CDMO focused on solid oral dosage forms, semi-solids, and sterile fill-finish for pharma and consumer health. Comparable in CDMO service model, European footprint, and diversified dosage-form capabilities similar to Biodue's broad pharmaceutical-form portfolio.

Broad incumbents

  • Lonza Group: Global CDMO leader in API, biologics, and cell & gene therapy manufacturing. Comparable as a CDMO, but with a far larger and more biotech-oriented portfolio than Biodue's nutraceutical, medical-device, and cosmetics mix.
  • Catalent: Global large-cap CDMO with extensive softgel, oral, sterile, and biologics capabilities. Comparable in CDMO service model and dosage-form breadth, but operates at a much larger scale and across broader therapeutic and biologics categories than Biodue.
  • CordenPharma: International CDMO providing API, drug product, and packaging services across multiple dosage forms. Comparable in integrated CDMO model and European roots, though focused more on prescription pharma than consumer health.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biodue social profiles

Digital presence

Biodue compliance and trust

Trust signal

Compliance5 records

Biodue financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biodue leadership team

Management profile

Number of profiles

Profiles1 record

Biodue subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Biodue funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biodue M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biodue

What does Biodue do?

Biodue is an Italian Contract Development and Manufacturing Organization (CDMO) that produces food supplements, medical devices, and cosmetics for third-party brands. The company operates seven manufacturing plants with more than 100 production lines and serves clients across 30 countries. Its offering combines R&D, formulation development, manufacturing, packaging, and regulatory support under proprietary platforms such as Caps in Caps technology.

Is Biodue a public or private company?

Biodue is a private company. It is classified as private equity controlled and is currently operating.

When was Biodue founded?

Biodue was founded in 1986. It employs 101 to 250 people.

Where is Biodue based?

Biodue is headquartered in Sambuca, Italy, in the Europe region.

How does Biodue make money?

One revenue line is on record: CDMO Manufacturing Services.

Who are Biodue's main competitors?

Direct peers on record are Delpharm, Fareva, Recipharm, Sirio Pharma and Aenova Group. Broad incumbents are Lonza Group, Catalent and CordenPharma.

Does Biodue have an API?

No public API is recorded for Biodue.

What industry is Biodue in?

Biodue's product category is Contract Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals